Fig. 4From: Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81–8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare settingTornado diagram indicating the effect of each independent variable on the resultant ICER while keeping all other variables constantrAHF-PFM: antihemophilic factor (recombinant) plasma/albumin-free method Back to article page